Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2011-03-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correct Medication List at and After Hospital Discharge
NCT05784194
The Pharmacist Follows You and Your Medication From Hospital to Your Daily Life and Investigate What This Means to You
NCT03079375
Oslo Pharmacist Intervention Study - Effect on Readmissions
NCT02336113
Prescribing Practice of Medication - Patient View.
NCT04588584
Optimisation of Nutrition and Medication for Acutely Admitted Older Medical Patients
NCT03741283
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This shall be recorded in the review of 30 patient with a focus on their medication list and follow them from admission to a month after discharge.
Medicine List in discharge summaries will be compared with medication written in journal during hospital stay and changes described in the text summaries and medication lists should be checked against the same journal.
Medicine list in the municipality one month after discharge shall be compared with discharge summaries and it will be mapped on the GP register, modified and considered if they are valid.
Hypothesis:
Medicine list is missing at admission by \> 50% of patients admitted acutely into hospital.
Medicine List at admission, when available, is often incomplete. When the medication list is not available at admission, its content is often incomplete even after the staff at reception have tried to gather information from different sources.
Changes of regular medication is not always present in the discharge summaries. The changes are not always justified in the discharge summaries. The GP often do not correct the medication list in the journal to the discharge summary.
The GP does not give the patient an updated printout of the list at the first medical consultation after admission.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acutly ill, Medical ward, consent
group of acutely ill patient who uses three or more drugs, must be able to give consent.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* using three or more drugs, prescription only
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oslo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Oslo
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mette Brekke, professor
Role: STUDY_DIRECTOR
University of Oslo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sykehuset Innlandet HF Gjøvik
Gjøvik, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MBKF-03-UiO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.